NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









TCG Crossover

TCG Crossover

Palo Alto, Californiatcgcrossover.com

Overview

TCG Crossover is a science-driven investment firm focused on the healthcare sector. The company invests in private and public companies and supports visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines. With offices in Palo Alto, San Francisco, and New York City, they have global capabilities and have supported companies in North America, Europe, and China.

Year Founded

2020

Portfolio Companies

34

Investments

CompanyDateStageLead
Ollin Biosciences, Inc.Jun 2026Series BLead
Accro Bioscience Inc.May 2026Series CCo-investor
Accro Bioscience Inc.May 2026Series CCo-investor
AdcendoApr 2026Series CCo-investor
ImmunicMar 2026Post-IPO FinancingCo-investor
View all investments

Key People

Dandan Dong

Venture Partner

Cariad Chester

Partner

Giuliano Marostica

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersPalo Alto, California
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.